The overexpression of EphA3 has been demonstrated in different cancers, such as lung cancers, melanomas, gastric carcinoma, leukemia [14–17], in B and T cell malignancies [18, 19] and in glioblastoma multiforme [20]. Here, EPHA3 is linked to cancer.